Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, Bronstein M, Chanson P, Fukuoka H, Gadelha M, Greenman Y, Gurnell M, Ho KKY, Honegger J, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Lodish M, Maiter D, Marcus HJ, McCormack A, Molitch M, Muir CA, Neggers S, Pereira AM, Pivonello R, Post K, Raverot G, Salvatori R, Samson SL, Shimon I, Spencer-Segal J, Vila G, Wass J, Melmed S (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19(12):722–740

Article  PubMed  Google Scholar 

Ciccarelli A, Daly AF, Beckers A (2005) The epidemiology of prolactinomas. Pituitary 8(1):3–6

Article  PubMed  Google Scholar 

Boguszewski CL, dos Santos CM, Sakamoto KS, Marini LC, de Souza AM, Azevedo M (2012) A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas. Pituitary 15(1):44–49

Article  CAS  PubMed  Google Scholar 

Dekkers OM, Lagro J, Burman P, Jørgensen JO, Romijn JA, Pereira AM (2010) Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. J Clin Endocrinol Metab 95(1):43–51

Article  CAS  PubMed  Google Scholar 

Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84(7):2518–2522

Article  CAS  PubMed  Google Scholar 

van Trigt VR, Zandbergen IM, Pelsma ICM, Bakker LEH, Verstegen MJT, van Furth WR, Biermasz NR (2023) Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery? Pituitary 26(5):611–621

Article  PubMed  PubMed Central  Google Scholar 

Martinkova J, Trejbalova L, Sasikova M, Benetin J, Valkovic P (2011) Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. Clin Neuropharmacol 34(5):179–181

Article  CAS  PubMed  Google Scholar 

Jane JA Jr., Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER Jr., Vance ML (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96(9):2732–2740

Article  CAS  PubMed  Google Scholar 

Erturk E, Tuncel E, Kiyici S, Ersoy C, Duran C, Imamoglu S (2005) Outcome of surgery for acromegaly performed by different surgeons: importance of surgical experience. Pituitary 8(2):93–97

Article  PubMed  Google Scholar 

Menucci M, Quiñones-Hinojosa A, Burger P, Salvatori R (2011) Effect of dopaminergic drug treatment on surgical findings in prolactinomas. Pituitary 14(1):68–74

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uzuner A, Yilmaz E, Caklili M, Selek A, Aydemir F, Cabuk B, Anik I, Ceylan S (2023) Endoscopic Transnasal Approach for Microprolactinomas with experience of 105 cases in a single Center: Paradigmal Shift for Conventional Medical Therapy. World Neurosurg 170:e858–e867

Article  PubMed  Google Scholar 

Salvatori R (2014) Surgical treatment of microprolactinomas: pros. Endocrine 47(3):725–729

Article  CAS  PubMed  Google Scholar 

Kharlip J, Salvatori R, Yenokyan G, Wand GS (2009) Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. J Clin Endocrinol Metab 94(7):2428–2436

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pereira AM (2011) Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia. Curr Opin Endocrinol Diabetes Obes 18(4):264–268

Article  CAS  PubMed  Google Scholar 

Andela CD, Scharloo M, Pereira AM, Kaptein AA, Biermasz NR (2015) Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18(5):752–776

Article  PubMed  Google Scholar 

Zygourakis CC, Imber BS, Chen R, Han SJ, Blevins L, Molinaro A, Kahn JG, Aghi MK (2017) Cost-effectiveness analysis of Surgical versus Medical Treatment of Prolactinomas. J Neurol Surg B Skull Base 78(2):125–131

PubMed  Google Scholar 

Zandbergen IM, Huntoon KM, White TG, Bakker LEH, Verstegen MJT, Ghalib LM, van Furth WR, Pelsma ICM, Dehdashti AR, Biermasz NR, Prevedello DM (2023) Efficacy and safety of endoscopic transsphenoidal resection for Prolactinoma: a retrospective Multicenter Case-series. Arch Med Res 54(8):102919

Article  CAS  PubMed  Google Scholar 

Dehdashti AR, Ganna A, Karabatsou K, Gentili F (2008) Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62(5):1006–1015 discussion 1015-7

PubMed  Google Scholar 

Park J, Golub D, White TG, Ruelle M, Quach ET, Yang K, Shah HA, Fastenberg JH, Eisenberg MB, Dehdashti AR (2023) Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery. Pituitary 26(5):629–641

Article  PubMed  Google Scholar 

Micko AS, Wöhrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122(4):803–811

Article  PubMed  Google Scholar 

Webster J, Piscitelli G, Polli A, I. Ferrari C, Ismail I, Scanlon MF, Cabergoline Comparative Study Group (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 331(14):904–909

Article  CAS  PubMed  Google Scholar 

Webster J, Piscitelli G, Polli A, D’Alberton A, Falsetti L, Ferrari C, Fioretti P, Giordano G, L’Hermite M, Ciccarelli E et al (1993) The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group. Clin Endocrinol (Oxf) 39(3):323–329

Article  CAS  PubMed  Google Scholar 

Roth BL (2007) Drugs and valvular heart disease. N Engl J Med 356(1):6–9

Article  CAS  PubMed  Google Scholar 

Akin S, Isikay I, Soylemezoglu F, Yucel T, Gurlek A, Berker M (2016) Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases. Acta Neurochir (Wien) 158(5):933–942

Article  PubMed  Google Scholar 

Zamanipoor Najafabadi AH, Zandbergen IM, de Vries F, Broersen LHA, Marle AM, Pereira WC, Peul OM, Dekkers WR, van Furth NR, Biermasz (2020) Surgery as a viable Alternative First-Line treatment for Prolactinoma patients. A systematic review and Meta-analysis. J Clin Endocrinol Metab 105(3):e32–41

Article  PubMed  Google Scholar 

Andereggen L, Frey J, Andres RH, Luedi MM, El-Koussy M, Widmer HR, Beck J, Mariani L, Seiler RW, Christ E (2021) First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center. J Endocrinol Invest 44(12):2621–2633

Article  CAS  PubMed  PubMed Central  Google Scholar 

Micko A, Vila G, Höftberger R, Knosp E, Wolfsberger S (2019) Endoscopic transsphenoidal surgery of Microprolactinomas: a reappraisal of cure rate based on Radiological Criteria. Neurosurgery 85(4):508–515

Article  PubMed  Google Scholar 

Baussart B, Villa C, Jouinot A, Raffin-Sanson ML, Foubert L, Cazabat L, Bernier M, Bonnet F, Dohan A, Bertherat J, Assié G, Gaillard S (2021) Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study. Eur J Endocrinol 185(6):783–791

Article  CAS  PubMed  Google Scholar 

Yagnik KJ, Erickson D, Bancos I, Atkinson JLD, Choby G, Peris-Celda M, Van Gompel JJ (2021) Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis. Pituitary 24(6):978–988

Article  PubMed  Google Scholar 

Abou-Al-Shaar H, Mallela AN, Patel A, Shariff RK, Shin SS, Choi PA, Faraji AH, Fazeli PK, Costacou T, Wang EW, Fernandez-Miranda JC, Snyderman CH, Gardner PA, Zenonos GA (2022) The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus. Pituitary 25(3):508–519

Article  PubMed  Google Scholar 

Babey M, Sahli R, Vajtai I, Andres RH, Seiler RW (2011) Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists. Pituitary 14(3):222–230